John Cox - 25 Mar 2024 Form 3 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role: Chief Executive Officer and President Exhibit Index: 24.1 Power of Attorney, Director
Signature: /s/ Richard Scalzo, Attorney-in-Fact
Issuer symbol: DYN
Transactions as of: 25 Mar 2024
Net transactions value: $0
Form type: 3
Filing time: 27 Mar 2024, 16:13:54 UTC
Previous filing: 11 Aug 2023
Next filing: 04 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DYN	Common Stock						10,000	25 Mar 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Chief Executive Officer and President Exhibit Index: 24.1 Power of Attorney